Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

February 1, 2012; Volume 53,Issue 2

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 9A-10A;

SNM Newsline

  • You have access
    From the Newsline Editor
    Harvey Ziessman
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 11N;
  • You have access
    MedPAC: Imaging Spending Down
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 11NA;
  • You have access
    What is an NMAA?
    Crystal Botkin and Robert Henkin
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 12N;
  • You have access
    SNM Submits Imaging Endpoint Comments to FDA
    Bonnie Clarke and Janette Merrill
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 13N;
  • You have access
    Strengthening Our Profession Through Community and Collaboration
    Frederic H. Fahey
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 14N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 15N-17N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 18N-21N;

Focus on Molecular Imaging

  • You have access
    Promising New Photon Detection Concepts for High-Resolution Clinical and Preclinical PET
    Craig S. Levin
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 167-170; DOI: https://doi.org/10.2967/jnumed.110.084343

Clinical Investigations

  • You have access
    Comparison of Clinical Tools for Measurements of Regional Stress and Rest Myocardial Blood Flow Assessed with 13N-Ammonia PET/CT
    Piotr J. Slomka, Erick Alexanderson, Rodrigo Jácome, Moises Jiménez, Edgar Romero, Aloha Meave, Ludovic Le Meunier, Magnus Dalhbom, Daniel S. Berman, Guido Germano and Heinrich Schelbert
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 171-181; DOI: https://doi.org/10.2967/jnumed.111.095398
  • You have access
    PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma
    Michel van Kruchten, Andor W.J.M. Glaudemans, Erik F.J. de Vries, Regina G.H. Beets-Tan, Carolien P. Schröder, Rudi A. Dierckx, Elisabeth G.E. de Vries and Geke A.P. Hospers
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 182-190; DOI: https://doi.org/10.2967/jnumed.111.092734
  • You have access
    Role of PET/CT in Staging and Evaluation of Treatment Response After 3 Cycles of Chemotherapy in Locally Advanced Retinoblastoma: A Prospective Study
    Venkatraman Radhakrishnan, Rakesh Kumar, Arun Malhotra and Sameer Bakhshi
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 191-198; DOI: https://doi.org/10.2967/jnumed.111.095836
  • You have access
    4′-[Methyl-11C]-Thiothymidine PET/CT for Proliferation Imaging in Non–Small Cell Lung Cancer
    Ryogo Minamimoto, Jun Toyohara, Ayako Seike, Hideyuki Ito, Hisako Endo, Miyako Morooka, Kazuhiko Nakajima, Takuya Mitsumoto, Kimiteru Ito, Momoko Okasaki, Kiichi Ishiwata and Kazuo Kubota
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 199-206; DOI: https://doi.org/10.2967/jnumed.111.095539
  • You have access
    Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis
    Vincent Dunet, Christine Rossier, Alfred Buck, Roger Stupp and John O. Prior
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 207-214; DOI: https://doi.org/10.2967/jnumed.111.096859
  • You have access
    Large Decreases in Standardized Uptake Values After Definitive Radiation Are Associated with Better Survival of Patients with Locally Advanced Non–Small Cell Lung Cancer
    Jose L. Lopez Guerra, Gregory Gladish, Ritsuko Komaki, Daniel Gomez, Yan Zhuang and Zhongxing Liao
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 225-233; DOI: https://doi.org/10.2967/jnumed.111.096305
  • You have access
    Increased In Vivo Expression of an Inflammatory Marker in Temporal Lobe Epilepsy
    Jussi Hirvonen, William C. Kreisl, Masahiro Fujita, Irene Dustin, Omar Khan, Shmuel Appel, Yi Zhang, Cheryl Morse, Victor W. Pike, Robert B. Innis and William H. Theodore
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 234-240; DOI: https://doi.org/10.2967/jnumed.111.091694
  • You have access
    The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
    George Youssef, Eugene Leung, Ilias Mylonas, Pablo Nery, Kathryn Williams, Gerald Wisenberg, Karen Y. Gulenchyn, Robert A. deKemp, Jean DaSilva, David Birnie, George A. Wells and Rob S.B. Beanlands
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 241-248; DOI: https://doi.org/10.2967/jnumed.111.090662

Clinical Investigation

  • You have access
    Tumor Dosimetry and Response for 153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Therapy of High-Risk Osteosarcoma
    Srinivasan Senthamizhchelvan, Robert F. Hobbs, Hong Song, Eric C. Frey, Zhe Zhang, Elwood Armour, Richard L. Wahl, David M. Loeb and George Sgouros
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 215-224; DOI: https://doi.org/10.2967/jnumed.111.096677

Brief Communications

  • You have access
    Triple-Negative Breast Cancer: Early Assessment with 18F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse
    David Groheux, Elif Hindié, Sylvie Giacchetti, Marc Delord, Anne-Sophie Hamy, Anne de Roquancourt, Laetitia Vercellino, Nathalie Berenger, Michel Marty and Marc Espié
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 249-254; DOI: https://doi.org/10.2967/jnumed.111.094045
  • You have access
    Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results
    Etienne Garin, Laurence Lenoir, Yan Rolland, Julien Edeline, Habiba Mesbah, Sophie Laffont, Philippe Porée, Bruno Clément, Jean-Luc Raoul and E. Boucher
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 255-263; DOI: https://doi.org/10.2967/jnumed.111.094235

Continuing Education

  • You have access
    Modern Nuclear Imaging for Paragangliomas: Beyond SPECT
    David Taïeb, Hartmut Neumann, Domenico Rubello, Adil Al-Nahhas, Benjamin Guillet and Elif Hindié
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 264-274; DOI: https://doi.org/10.2967/jnumed.111.098152

Basic Science Investigations

  • You have access
    Stratification of Nucleoside Analog Chemotherapy Using 1-(2′-Deoxy-2′-18F-Fluoro-β-d-Arabinofuranosyl)Cytosine and 1-(2′-Deoxy-2′-18F-Fluoro-β-l-Arabinofuranosyl)-5-Methylcytosine PET
    Jason T. Lee, Dean O. Campbell, Nagichettiar Satyamurthy, Johannes Czernin and Caius G. Radu
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 275-280; DOI: https://doi.org/10.2967/jnumed.111.090407
  • You have access
    Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest 18F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma
    Lars Stelter, Michael J. Evans, Achim A. Jungbluth, Pat Zanzonico, Gerd Ritter, Thomas Ku, Eric Rosenfeld, John S. Bomalaski, Lloyd Old and Steven M. Larson
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 281-286; DOI: https://doi.org/10.2967/jnumed.111.092973
  • You have access
    Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-18F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)Acetamide
    Dewei Tang, Matthew R. Hight, Eliot T. McKinley, Allie Fu, Jason R. Buck, R. Adam Smith, Mohammed Noor Tantawy, Todd E. Peterson, Daniel C. Colvin, M. Sib Ansari, Michael Nickels and H. Charles Manning
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 287-294; DOI: https://doi.org/10.2967/jnumed.111.095653
  • You have access
    Radiosynthesis and Characterization of 11C-GSK215083 as a PET Radioligand for the 5-HT6 Receptor
    Christine A. Parker, Roger N. Gunn, Eugenii A. Rabiner, Mark Slifstein, Robert Comley, Cristian Salinas, Christopher N. Johnson, Steen Jakobsen, Sylvain Houle, Marc Laruelle, Vincent J. Cunningham and Laurent Martarello
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 295-303; DOI: https://doi.org/10.2967/jnumed.111.093419
  • You have access
    Targeted Near-Infrared Imaging of the Erythropoietin Receptor in Human Lung Cancer Xenografts
    Dennis Doleschel, Olaf Mundigl, Axel Wessner, Felix Gremse, Julie Bachmann, Agustin Rodriguez, Ursula Klingmüller, Michael Jarsch, Fabian Kiessling and Wiltrud Lederle
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 304-311; DOI: https://doi.org/10.2967/jnumed.111.091124
  • You have access
    Proof-of-Concept Study of Monitoring Cancer Drug Therapy with Cerenkov Luminescence Imaging
    Yingding Xu, Edwin Chang, Hongguang Liu, Han Jiang, Sanjiv Sam Gambhir and Zhen Cheng
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 312-317; DOI: https://doi.org/10.2967/jnumed.111.094623
  • You have access
    Molecular Imaging of Early αvβ3 Integrin Expression Predicts Long-Term Left-Ventricle Remodeling After Myocardial Infarction in Rats
    Hossam M. Sherif, Antti Saraste, Stephan G. Nekolla, Eliane Weidl, Sybille Reder, Arne Tapfer, Martina Rudelius, Takahiro Higuchi, René M. Botnar, Hans-Jürgen Wester and Markus Schwaiger
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 318-323; DOI: https://doi.org/10.2967/jnumed.111.091652
  • You have access
    Validation of an Automatic Dose Injection System for Ictal SPECT in Epilepsy
    Xavier Setoain, Javier Pavía, Eulalia Serés, Ramiro Garcia, Maria Mar Carreño, Antonio Donaire, Sebastià Rubí, Nuria Bargalló, Jordi Rumià, Teresa Boget, Luís Pintor, David Fuster and Francesca Pons
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 324-329; DOI: https://doi.org/10.2967/jnumed.111.093211
  • You have access
    Radiation Dosimetry and Biodistribution of the TSPO Ligand 11C-DPA-713 in Humans
    Christopher J. Endres, Jennifer M. Coughlin, Kenneth L. Gage, Crystal C. Watkins, Michael Kassiou and Martin G. Pomper
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 330-335; DOI: https://doi.org/10.2967/jnumed.111.094565

Special Contribution

  • You have access
    New Pathways to Medicare Coverage for Innovative PET Radiopharmaceuticals: Report of a Medical Imaging & Technology Alliance (MITA) Workshop
    Bruce J. Hillman, Richard A. Frank and Gail M. Rodriguez
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 336-342; DOI: https://doi.org/10.2967/jnumed.111.098947

Erratum

  • You have access
    Erratum
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 342;

Book Review

  • You have access
    The Fever: How Malaria Has Ruled Humankind for 500,000 Years
    Carlos J. Carcamo and Robert Matthews
    Journal of Nuclear Medicine February 1, 2012, 53 (2) 343-344; DOI: https://doi.org/10.2967/jnumed.111.097527
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 53 (2)
Journal of Nuclear Medicine
Vol. 53, Issue 2
February 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma
  • Triple-Negative Breast Cancer: Early Assessment with 18F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse
  • Proof-of-Concept Study of Monitoring Cancer Drug Therapy with Cerenkov Luminescence Imaging
Sign up for alerts

Jump to

  • This Month in JNM
  • SNM Newsline
  • Focus on Molecular Imaging
  • Clinical Investigations
  • Clinical Investigation
  • Brief Communications
  • Continuing Education
  • Basic Science Investigations
  • Special Contribution
  • Erratum
  • Book Review
  • Most Cited
  • Most Read
Loading
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
  • Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
  • Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA
  • Fibroblast Activation Protein–Targeted PET/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET/CT
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire